Navigation Links
Venture Investors to open Michigan office

Madison, Wis. - In a move that could bring additional investment partners to Wisconsin deals, Venture Investors of Madison will open an office in Ann Arbor, Mich. after receiving money from a Michigan venture fund.

The Madison venture capital firm, which recently moved into a larger space in the MGE Innovation Center in TomoTherapy, Virent Energy Systems, and NimbleGen Systems in its portfolio of companies.

Venture Michigan Fund I was established after Michigan Gov. Jennifer Granholm called for a new source of start-up funding......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 01/24/07


Related biology technology :

1. Venture Investors early-stage fund grows to $115 million
2. Berbee to expand at New Venture Center
3. Fergus joins Baird Venture Partners, Caden Bio
4. Avolte Venture Partners reaches capital goal
5. Venture capital above $6B for third straight quarter
6. Venture-backed firms could become eligible for federal SBIR grants
7. Venture capitalist defends Wisconsin CAPCOs
8. Venture Investors looks to fund 20 companies
9. SWIB plans to invest $50m with Mason Wells and Venture Investors
10. Six Wisconsin firms to present at BIO Mid-America VentureForum
11. MDC "Venture Debt" loans help fund tech firms
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)...  VWR Corporation (NASDAQ: VWR), the leading global independent provider ... today reported its financial results for the fourth quarter and ... 4Q16 record quarterly net sales of $1.13 ... basis. 4Q16 EMEA-APAC segment net ... the Americas net sales increased 2.5%, or down 0.9% on ...
(Date:2/23/2017)... SAN RAFAEL, Calif., Feb. 23, 2017 ... of U.S. dollars, except per share data, unaudited)Three Months ... ChangeTotal BioMarin Revenue $ ...     22832%$ 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  ...
(Date:2/23/2017)... 23, 2017  MIODx announced today that it ... immunotherapy technologies from the University of California, San ... to monitor a patient for response to immune ... The second license extends the technology with a ... to have an immune-related adverse event (IRAE) from ...
(Date:2/23/2017)... Feb. 23, 2017  Imanis Life Sciences announced ... of oncolytic vaccinia viruses for virotherapy research. These ... of Genelux,s proprietary, vaccinia virus-based technology platform for ... enter into a partnership with Genelux to offer ... viruses for use in research," said Dr. ...
Breaking Biology Technology:
(Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
Breaking Biology News(10 mins):